Thank you for subscribing!
Next Investors Aug 30, 2024
Our health tech Investment and 2021 Tech Pick of the Year, Oneview Healthcare (ASX: ONE) released its half year results yesterday, which had some clues as to what the next six months could hold.
Next Investors May 10, 2024
Oneview Healthcare (ASX: ONE) is currently our largest shareholding. The reason we hold a large position comes down to our strong conviction that hospitals are well overdue for a technology upgrade.
Finfeed Archived May 10, 2021
Oneview Healthcare’s (ASX: ONE) technology partner NYU Langone Health has released an informative webinar, discussing the group’s digital patient experience strategy and how Oneview Healthcare’s Care Experience Platform has helped improve patient, family and clinician experience.
Finfeed Archived Apr 01, 2021
Yesterday, Oneview Healthcare (ASX: ONE) announced the launch of CXP Cloud Enterprise, the world’s first and only cloud-based care experience platform. Deploying Microsoft Azure technology, this platform makes it easier for health systems to support personalised, whole person care.
Get expert stock analysis direct in your inbox
Finfeed Archived Mar 26, 2021
Today, Oneview Healthcare plc (ASX: ONE) announced it has been awarded ISO 27001 certification, allowing the company to assure its clients and other stakeholders the safe security of their information.
Next Investors Mar 19, 2021
Oneview Health (ASX: ONE) is our Tech Pick of the Year for 2021 and we believe this is potentially the most undervalued stock we have ever seen.
Next Investors Feb 09, 2021
In the last three trading sessions the MyFiziq (ASX: MYQ) share price has surged from around $1 to finish at $1.34 yesterday. That’s on big volumes with no news.
Finfeed Archived Dec 22, 2020
MyFiziq Limited (ASX: MYQ) and Biomorphik Pty Ltd have completed the initial fast to market product, which comprises a set of standalone iOS and Android applications, branded in Biomorphik colours.
Finfeed Archived Nov 25, 2020
MyFiziq Limited (ASX:MYQ) has today announced that Body Composition Technologies Pte Ltd (BCT), its 54% owned joint venture partner, has had a second peer-reviewed study published.
Join Our Mailing List
